Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene
- 1 November 2007
- journal article
- Published by Wiley in Cancer Science
- Vol. 98 (11) , 1701-1705
Abstract
The high incidence of multiple primary tumors (MPT) is a significant problem in head and neck tumor treatment. Recent studies suggest that carriers of heterozygous mutations in the NBS1 gene have an increased risk of malignant tumor development. The aim of our research was to assess the frequency of NBS1 mutations in patients with larynx cancer only (LC) and with MPT. The MPT group consisted of patients with one cancer localized to the larynx (primary or second) and another at another site. DNA from 175 patients with LC and 93 patients with MPT was analyzed using the single-strand conformation polymorphism method and direct sequencing. We found nine carriers of the I171V mutation among these 268 cancer patients and only one carrier among 500 population controls (0.2%). Four carriers of the I171V mutation were detected among 175 LC patients (2.3%) and five among 93 patients with MPT (5.4%). The frequencies of the I171V mutation carriers in LC and MPT patients were significantly higher than in controls (odds ratio [OR] = 11.7, confidence interval [CI] 1.3-105.2, P = 0.0175 and OR = 28.35, CI 3.27-245.7, P = 0.0005, respectively). In one individual with LC, a novel molecular variant, c.1222 A > G (p.K408E), was identified. No carriers of R215W or 657del5 NBS1 mutations were found in the present study. These findings imply that heterozygous carriers of the I171V mutation are prone to the development of larynx cancer and may, in addition, display an increased risk of second tumors at other sites.Keywords
This publication has 35 references indexed in Scilit:
- Heterozygous carriers of Nijmegen Breakage Syndrome have a distinct gene expression phenotypeGenome Research, 2006
- Carrier frequency of mutation 657del5 in the NBS1 gene in a population of polish pediatric patients with sporadic lymphoid malignanciesInternational Journal of Cancer, 2005
- Polymorphisms of DNA repair genes and risk of non-small cell lung cancerCarcinogenesis, 2005
- NBS1 Expression as a Prognostic Marker in Uveal MelanomaClinical Cancer Research, 2005
- Multiplex single-tube screening for mutations in the Nijmegen Breakage Syndrome (NBS1) gene in Hodgkin's and non-Hodgkin's lymphoma patients of Slavic originEuropean Journal of Human Genetics, 2003
- Chromosome instability and nibrin protein variants in NBS heterozygotesEuropean Journal of Human Genetics, 2003
- Nijmegen breakage syndrome gene, NBS1, and molecular links to factors for genome stabilityOncogene, 2002
- New mutations and protein variants of NBS1 are identified in cancer cell linesGenes, Chromosomes and Cancer, 2002
- NBS1 Localizes to γ-H2AX Foci through Interaction with the FHA/BRCT DomainCurrent Biology, 2002
- Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populationsEuropean Journal of Human Genetics, 2000